The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita Alaggio,Catalina Amador,Ioannis Anagnostopoulos,Ayoma D. Attygalle,Iguaracyra Barreto de Oliveira Araujo,Emilio Berti,Govind Bhagat,Anita Maria Borges,Daniel Boyer,Mariarita Calaminici,Amy Chadburn,John K. C. Chan,Wah Cheuk,Wee-Joo Chng,John K. Choi,Shih-Sung Chuang,Sarah E. Coupland,Magdalena Czader,Sandeep S. Dave,Daphne de Jong,Ming-Qing Du,Kojo S. Elenitoba-Johnson,Judith Ferry,Julia Geyer,Dita Gratzinger,Joan Guitart,Sumeet Gujral,Marian Harris,Christine J. Harrison,Sylvia Hartmann,Andreas Hochhaus,Patty M. Jansen,Kennosuke Karube,Werner Kempf,Joseph Khoury,Hiroshi Kimura,Wolfram Klapper,Alexandra E. Kovach,Shaji Kumar,Alexander J. Lazar,Stefano Lazzi,Lorenzo Leoncini,Nelson Leung,Vasiliki Leventaki,Xiao-Qiu Li,Megan S. Lim,Wei-Ping Liu,Abner Louissaint Jr.,Andrea Marcogliese,L. Jeffrey Medeiros,Michael Michal,Roberto N. Miranda,Christina Mitteldorf,Santiago Montes-Moreno,William Morice,Valentina Nardi,Kikkeri N. Naresh,Yasodha Natkunam,Siok-Bian Ng,Ilske Oschlies,German Ott,Marie Parrens,Melissa Pulitzer,S. Vincent Rajkumar,Andrew C. Rawstron,Karen Rech,Andreas Rosenwald,Jonathan Said,Clémentine Sarkozy,Shahin Sayed,Caner Saygin,Anna Schuh,William Sewell,Reiner Siebert,Aliyah R. Sohani,Reuben Tooze,Alexandra Traverse-Glehen,Francisco Vega,Beatrice Vergier,Ashutosh D. Wechalekar,Brent Wood,Luc Xerri,Wenbin Xiao
DOI: https://doi.org/10.1038/s41375-022-01620-2
2022-06-23
Leukemia
Abstract:We herein present an overview of the upcoming 5 th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4 th edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5 th edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.
oncology,hematology